What’s the financial overview for Ambu A/S?

Ambu A/S’s market cap stands at $0.004 trillion right now. The company’s trailing twelve-month earnings per share EPS is $0.22, with a dividend yield of 0.18%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

How can I analyze historical data?

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

What does Ambu A/S Stock ROE tell us?

Ambu A/S stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

What is per share price for Ambu A/S?

The Ambu A/S stock per share price is $15.85.

Ambu A/S

AMBBY•PNK

Healthcare

Medical - Devices

$15.85

$0.99(6.68%)

Ambu A/S (AMBBY) Financial Performance & Income Statement Overview

Explore the financials of Ambu A/S (AMBBY), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth

12.90%

↑ 12.90%

Operating Income Growth

113.58%

↑ 113.58%

Net Income Growth

39.88%

↑ 39.88%

Operating Cash Flow Growth

56.95%

↑ 56.95%

Operating Margin

13.58%

↑ 13.58%

Gross Margin

60.27%

↑ 60.27%

Net Profit Margin

6.34%

↑ 6.34%

ROE

6.42%

↑ 6.42%

ROIC

12.35%

↑ 12.35%

Ambu A/S (AMBBY) Income Statement & Financial Overview

View the income breakdown for Ambu A/S AMBBY across both annual and quarterly reports.

Metric	Q2 2025	Q1 2025	Q4 2024	Q3 2024
Revenue	$1.55B	$1.51B	$1.39B	$1.38B
Cost of Revenue	$612.00M	$585.00M	$570.00M	$551.00M
Gross Profit	$942.00M	$925.00M	$817.00M	$832.00M
Gross Profit Ratio	$0.61	$0.61	$0.59	$0.60
R&D Expenses	$88.00M	$79.00M	$86.00M	$84.00M
SG&A Expenses	$630.00M	$603.00M	$584.00M	$570.00M
Operating Expenses	$718.00M	$682.00M	$670.00M	$654.00M
Total Costs & Expenses	$1.33B	$1.27B	$1.24B	$1.21B
Interest Income	$4.00M	$4.00M	$6.00M	$3.00M
Interest Expense	$20.00M	$10.00M	$0.00	$7.00M
Depreciation & Amortization	$94.00M	$88.00M	$88.00M	$89.00M
EBITDA	$322.00M	$335.00M	$248.00M	$270.00M
EBITDA Ratio	$0.21	$0.22	$0.18	$0.20
Operating Income	$224.00M	$243.00M	-$187.00M	$178.00M
Operating Income Ratio	$0.14	$0.16	-$0.13	$0.13
Other Income/Expenses (Net)	-$16.00M	-$6.00M	$6.00M	-$4.00M
Income Before Tax	$208.00M	$237.00M	-$181.00M	$174.00M
Income Before Tax Ratio	$0.13	$0.16	-$0.13	$0.13
Income Tax Expense	$20.00M	$54.00M	-$46.00M	$40.00M
Net Income	$188.00M	$183.00M	-$135.00M	$134.00M
Net Income Ratio	$0.12	$0.12	-$0.10	$0.10
EPS	$0.71	$0.68	-$0.51	$0.50
Diluted EPS	$0.71	$0.68	-$0.51	$0.50
Weighted Avg Shares Outstanding	$264.79M	$269.12M	$264.71M	$268.00M
Weighted Avg Shares Outstanding (Diluted)	$264.79M	$269.12M	$264.71M	$268.00M

Over the last four quarters, Ambu A/S achieved steady financial progress, growing revenue from $1.38B in Q3 2024 to $1.55B in Q2 2025. Gross profit stayed firm with margins at 61% in Q2 2025 versus 60% in Q3 2024. Operating income totaled $224.00M in Q2 2025, maintaining a 14% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $322.00M. Net income rose to $188.00M, with EPS at $0.71. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;